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Abstract 
The perfusion mode of a continuous cell culture bioreactor was modified to establish a closed loop 
system. Eighty percent of the spent medium was re-used twice. The medium cycle bioreactor unit was 
operated sterile and uncomplicated without a technical retention system for the high molecular weight 
substances. Therefore, only 20% of the actual medium was necessary to run the recycling process. 
During seven days culture time in a two liter scale 5 grams of IgG1 type monoclonal antibody was 
produced. During that period the cell specific productivity was constant. Renewal of proteins was 
omitted because the protein content in the system persisted at a high level. Therefore, self-conditioning 
substances of the cells were retained in the system as well as the expensive medium components 
(proteins with catalytic or stimulating function). Seventy to 80% of medium costs and medium quantity 
were saved for each medium recycling step. Only cheap metabolites that areconsumed by the cells had to 
be supplemented. Uptake rates of glucose and amino acids were calculated to establish a suitable 
supplementation mixture for the recirculated medium. 
Introduction 
Production processes with cell cultures rank with 
the most expensive procedures in biotechnology. 
Now as before the upstream processing cause th
main part of the process costs. Mammalian cell 
culture is rather uneconomical, because the major 
part of the medium is not exploited, but wasted. 
In respect to a more economic use of culture 
process components and a reduction of environ- 
mental burden it is advantageous to re-use the 
spent medium. Re-use of a serum-containing me- 
dium was described by Mizrahi and Avihoo 
(1977). This paper presents anew procedure with 
a serum-free medium, the combination of cell 
retention and continuous medium recirculation 
(Kempken et al., 1991a). 
Development of the medium cycle bioreactor 
Cell retention in the bioreactor 
Cell retention became rationalised for the slow 
growth rate of mammalian cells. Synthetic mem- 
branes are used in numerous separation problems 
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in biotechnology (Chmiel et al., 1985) and enable 
a reliable cell retention by microfiltration of the 
bioreactor fluid. Concerning cell cultures, sys- 
tems were developed ealing with medium filtra- 
tion inside the bioreactor. Double membrane stir- 
rers are very proper for this (Biintemeyer et al., 
1987). A hydrophilized polypropylene membrane 
is used for long-term filtration (Lehmann et al., 
1988). This kind of cell retention permits an 
effective perfusion mode in homogeneous con- 
tinuous systems (Btintemeyer tal., 1990) resul- 
ting in reproducible st ady state cultivation (Btin- 
temeyer et al., 1991). 
Recycling of the cell culture medium 
For the preceding arguments medium recycling 
should be an advantageous completion of the 
perfusion mode. We recommend a loop or a 
bypass ystem which passes the major part of the 
spent medium back into the bioreactor. A small 
part should be wasted as usual to avoid an increase 
of toxic metabolites that are formed by the cells. 
Hence, a dilution step and a supplementation f 
consumed nutrients are necessary to run the re- 
cycling procedure (Lehmann et al., 1989). A 
continuous perfusion mode with subsequent ul- 
trafiltration module for example allows an online 
recirculation of the high molecular weight me- 
dium components (Btintemeyer, 1988). The parti- 
tion of the bioreactor outlet fluid in high and low 
molecular weight branches can be extended to an 
overall conception of product harvest and inhibi- 
tor removal in the protein branch, and detoxifica- 
tion and nutrient supplementation in the protein- 
free branch (Lehmann et al., 1989). For the 
feasibility of such recirculation processes no loss 
of productivity must occur plus quality, stability 
and purity of the product must be maintained. 
Hence, we have to investigate whether an accu- 
mulation of substances with inhibiting or toxic 
effects is found in respect o the re-use of spent 
media. A detoxification of such substances on the 
low molecular side was performed for example 
by RCnning and Schartum (1990) with gel filtra- 
tion, and by our group with membrane extraction 
(Ltitkemeyer et al., 1991) and electrodialysis 
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Fig. 1. MCB status at the start of the perfusion period. 
(Kempken et al., 1990a). We have no reliable 
findings about s ructure and effect of high mo- 
lecular weight inhibitors yet. For these considera- 
tions the medium cycle bioreactor was developed 
essentially as a system for the accumulation and 
discovery of possible inhibitors. 
Principle of the medium cycle bioreactor 
Using the medium cycle bioreactor, the perfusion 
mode is extended to form a closed loop system. 
Batch and perfusion start in the same way as in 
classic perfusion mode (Fig. 1). Eighty percent of 
the perfused medium is collected cell-free as 
perfusion outlet fluid and 20% as cell-containing 
bleed. When the medium inlet tank is empty (Fig. 
2), the usual procedure is to take the product out 
of bleed tank and perfusion outlet tank and to 
continue the culture with new medium. On the 
medium ~onc~tmte 
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Fig. 2. MCB status at the end of the perfusion period (before 
supplementation). 
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Fig. 3. MCB status at the start of the first recycling period (after 
supplementation). 
contrary we pump the entire perfusion outlet 
medium back into the bioreactor and use it again. 
When using the double membrane stirrer, all you 
need to do is to change the direction of the 
perfusion pumps (Figs. 2 and 3) and to add a 
'medium concentrate' in the same quantity as 
spent medium leaves the system via bleed. Hence, 
80% of the spent medium is recycled. Thr pro- 
duct is taken out continuously by the bleed. The 
bleed rate, about 20% of the dilution rate, is 
performed as well to maintain a steady state of 
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the culture and to avoid the accumulation of toxic 
substances by dilution (Kempken et al., 1990b). 
Only 20% instead of 100% of new medium is 
needed for the following perfusion period, which 
is equivalent o the first recycling period. This 
new medium is the 'medium concentrate', consis- 
ting of new medium supplemented with amino 
acids and glucose corresponding to the recycled 
volume (Table 1). The price for this concentrate 
is about the same as for new medium, because 
amino acids and glucose are very cheap in respect 
to the protein components (Table 2). Approxi- 
mately the same nutrient composition and con- 
centrations as in new medium are reinstalled, 
when the medium concentrate is added to the 
spent perfusion medium (Figs. 4, 5 and 6). 
The first recycling period is done with the 
supplemented spent medium until the medium 
inlet tank is empty again. A new 20% of the 
dilution rate is leaving the system via bleed tank 
and 80% is collected cell-free in the perfusion 
outlet tank (Fig. 7). The bleed leaves the system 
for product harvest and is replaced as in the first 
recycling period by a volume of medium concen- 
trate corresponding to the bleed volume (Fig. 8). 
Table 1. Composition ofmedium and medium concentrate. 
amino A B C Medium composition 
acid 
Asp 50 100 450 
Glu 50 150 700 
Ash 50 150 700 
Ser 250 500 2250 
His 150 300 1350 
Gin 2500 6500 30000 
Gly 250 500 2250 
Thr 450 1350 6300 
Arg 700 1400 6300 
Ala 50 50 250 
Tyr 215 430 1935 
Trp 45 90 405 
Met 115 345 1610 
Val 450 900 4050 
Phe 215 430 1935 
Ile 415 830 3735 
Leu 450 1350 6300 
Lys 500 1000 4500 
IM 
iM 
xM 
xM 
xM 
.tM 
xM 
~M 
.tM 
IM 
.tM 
.tM 
.tM 
.tM 
LtM 
aM 
LtM 
aM 
1:1 mixture of DMEM and Ham's F 12 
(basic medium), supplemented by:
50 gM ethanolamine 
2 mM sodium pymvate 
500 mg/l bovine serum albumin 
10 rag/1 bovine insulin 
I0 mg/1 human transfeITin 
besides amino acids (B-A) 
List of amino acids (on the left side) 
A: concentration in basic medium 
(1:1 mixture of DMEM and F 12) 
B: concentration n the supplemented 
basic medium (totally) 
C: concentration n medium concentrate 
1 liter of it is used to supplement 
4 liters of spent medium 
C=4.B +03 -A)  
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Table 2. Costs for medium and medium concentrate. 
Substance Medium Medium concentrate 
bovine serum albumine 0.17 DM 0 DM 
oleic acid 0 DM 0 DM 
bovine insulin 6.20 DM 6.20 DM 
human transferrin 2.58 DM 2.58 DM 
ferric chloride 0 DM 0 DM 
basic medium 1.40 DM 1.40 DM 
sodium hydrogen carbonate 0.089 DM 0.089 DM 
ethanolamine 0 DM 0 DM 
sodium pyruvate 0.12 DM 0.12 DM 
glutamine 0.20 DM 0.74 DM 
glucose 0 DM 0.14 DM 
extra pure water 0.16 DM 0.16 DM 
amino acids (besides glutamine): 100 Pfg. = 1 DM (German Mark) 
Asp 0.085 Pfg. 0.43 Pfg. 
Glu 0.088 Pfg. 0.44 Pfg. 
Asn 1.80 Pfg. 9.01 Pfg. 
Ser 3.20 Pfg. 15.98 Pfg. 
His 1.80 Pfg. 8.99 Pfg. 
Gly 0.11 Pfg. 0.55 Pfg. 
Thr 5.71 Pfg. 28.57 Pfg. 
Arg 2.60 Pfg. 12.99 Pfg. 
Tyr 1.34 Pfg. 6.70 Pfg. 
Trp 0.68 Pfg. 3.40 Pfg. 
Met 0.96 Pfg. 4.80 Pfg. 
Val 1.65 Pfg. 8.23 Pfg. 
Phe 1.03 Pfg. 5.15 Pfg. 
Ile 5.12 Pfg. 25.60 Pfg. 
Leu 2.83 Pfg. 14.17 Pfg. 
Lys 0.88 Pfg. 4.39 Pfg. 
addition: 11.22 DM per liter 12.93 DM per liter 
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Fig. 9. Amino acid concentration pattern in the peffusion outlet 
tank of Fig. 7. 
Again the concentrations and composition of nu- 
trients are about equivalent to those in fresh 
medium (Figs. 9 and 10). In this way the second 
recycling period is started. The next periods of 
recycling and supplementation are alike. 
m~'fium omomL-a~ 
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Fig. 7. MCB status at the end of the first recycling period 
(before supplementation). 
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Fig. 10. Amino acid concentration pattern in the perfusion inlet 
tank o f  Fig. 8. 
Protein content during a MCB fermentation 
The protein content in the system is kept at a high 
level. Eighty percent of the high molecular weight 
substances are retained in a very simple way 
without using a technical retention unit. The 
process is uncomplicated and the costs for the 
retention unit are omitted. Conditioning factors 
produced by the ceils persist in the MCB system. 
The protein components of the medium are like- 
wise kept in the system and are not renewed. 
They mostly have catalytic or stimulating func- 
tions and are the main part of medium costs. 
Therefore, its retention in the system is a substan- 
tial benefit. 
Product content during a MCB fermentation 
Fig. 8. MCB status at he start of the second recycling period 
(after supplementation). The residence time of the product in the system is 
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enlarged considerably by the MCB procedure. If
it is not absorbed, the product stays about five 
times longer in the MCB than in normal perfu- 
sion systems. In that time the product must be 
stable. Concerning the undermentioned culture 
the cell specific productivity was constant during 
continuous cultivation. Activity, stability and pu- 
rity of the product have to be analyzed as well. 
Inhibitors during a MCB fermentation 
With a prolonged residence time it is important 
whether detrimental substances, formed and re- 
leased by the cells, will accumulate beyond a 
tolerance l vel. The bleed rate has to be sufficient 
for the removal of inhibitors or toxic substances. 
Otherwise a loss in cell growth or productivity 
can be expected. Selecting an appropriate cell 
bleed rate the MCB can be used either to accumu- 
late and detect oxic substances or to dilute those 
substances as a detoxification process. 
Detoxification is by dilution only. Special eli- 
mination procedures for detrimental substances 
like lactate (Kempken et al., 1990a) or ammo- 
nium (Ltitkemeyer t al., 1991, Kempken et al., 
1991b, Newland et al., 1990) are omitted. Hence, 
the overall effect of inhibitors and toxic substan- 
ces will arise during the MCB operation in the 
case when production reaches effective concen- 
trations (Kempken et al., 1991c). 
Nutrient requirements during a MCB fermenta- 
tion 
In contrast to other continuous culture processes, 
supplementation is restricted to those low mo- 
lecular weight nutrients that are in fact consumed 
by the cells. In addition the supply of fresh 
medium is necessary to equate with the spent 
medium that leaves the system via bleed (Kemp- 
ken et al., 1990b). Hence, many medium compo- 
nents have to be analyzed, e.g. glucose, amino 
acids, organic acids, inorganic ions. A suitable 
supplementation mixture is calculated from the 
analysis data and serves as a standardized me- 
dium concentrate for that particular cell line. 
Savings due to the MCB process 
During the recycling run about 80% of medium 
and therefore costs are saved. Since the require- 
ment for new media is reduced, time and costs for 
medium preparation, sterile filtration and sterile 
testing are also saved. We also get a drop in costs 
for inactivation of spent medium if it is demanded 
by law (Hasskarl, 1990a) and preferably per- 
formed by autoclaving (Hasskarl, 1990b) with 
high energy costs. 
The entire MCB system is operated sterile. 
Additional sterile filtration procedures due to the 
recirculation process are omitted. The MCB pro- 
cess is cheap and uncomplicated because proteins 
are re-used without a technical retention system 
and because detoxification is by dilution only. 
We expect a drop of process costs especially in 
large scale production systems. 
Materials and methods 
The basic bioreactor was a B. Braun Biostat BF 
(B. Braun Diessel Biotech GmbH, FRG) at a two 
liter scale. It was equipped with a double mem- 
brane stirrer with 5.30 m polypropylene hollow 
fiber membrane tubing for aeration and 3.30 m 
hydrophilized polypropylene hollow fiber mem- 
brane tubing for cell-free medium exchange. A
bioreactor control unit DCU (B. Braun Diessel 
Biotech GmbH, FRG) and a perfusion mode with 
medium backflush procedure as described by 
Btintemeyer (1988) were used. The microfiltra- 
tion membrane (Enka AG, FRG) was connected 
at the input side via a peristaltic pump (Watson- 
Marlow Ltd., GB) with the medium inlet tank and 
at the output side via another pump with the 
perfusion outlet ank. These two perfusion pumps 
were controlled to create a process cycle of 
alternatively harvesting and feeding depending 
on reactor volume and pump speed. Temperature 
was set at 37~ stirrer speed to 30 rpm, pH to 
7.10 and gas supply to 40% air saturation. 
The cell line used in this study was a mouse-rat 
hybridoma (ATCC HB 58). This cell ine secretes 
a rat monoclonal antibody IgG1 type specific for 
mouse antibody ~ light chains. Two or three 
samples per day were taken from the bioreactor 
vessel and analyzed as follows. The cell number 
was counted microscopically by trypan blue ex- 
clusion. Glucose and lactate were analyzed using 
the YSI 2000 analyzer (Yellow Springs Instru- 
ments, Ohio, USA), ammonium using an am- 
monia selective electrode with microprocessor 
pH/ION meter pMX 2000 (WTW GmbH, FRG). 
The free amino acids in the samples were ana- 
lyzed by the automated reversed phase HPLC 
system 400 (Kontron GmbH, FRG) with pre- 
column derivatization using the OPA method 
(Btintemeyer et al., 1991). Antibody concentra- 
tions in the supernatant were analyzed using a 
kinetic sandwich ELISA method and the EL 311 
autoreader (Tecnomara GmbH, FRG). 
The serum-free medium used in this study was 
a 1:1 mixture of DMEM and Ham's F 12, supple- 
mented by 50 ~tM ethanolamine, 2 mM sodium 
pyruvate, 500 mg/1BSA, 10 mg/1 human transfer- 
rin and 10 mg/1 bovine insulin. In addition the 
following amino acid concentrations were added: 
Asp 50 ~tM, Glu 100 ~tM, Asn 100 ~tM, Ser 250 
~tM, His 150 p.M, Gin 4000 ~tM, Gly 250 I.tM, 
Thr 900 ~tM, Arg 700 ~tM, Tyr 215 ktM, Trp 45 
~tM, Met 230 ktM, Val 450 p.M, Phe 215 ~tM, Ile 
415 ~tM, Leu 900 I.tM, Lys 500 ~tM. 
This medium was used for batch cultivation 
Table 3. Periods of the MCB fermentation. 
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and for perfusion until medium recycling started. 
At the start of the recycling periods (at 90 h and 
137 h culture time) the bleed, leaving the system, 
was replaced by medium concentrate of the same 
quantity. Medium and medium concentrate com- 
positions are listed in Table 1, its costs in Table 2. 
The culture was divided into seven periods 
(Table 3) to calculate the specific productivity. 
Periods 4 and 6 were formed, as the cell bleed 
started at the end of the first perfusion period and 
as the bleed rate was raised at the end of the first 
recycling period. 
Functions were correlated mathematically to 
the growth curve (Fig. 11) and to the product 
concentration curve (Fig. 12). From the function, 
the first order derivative of the function and the 
equations for the cell specific parameters (Pitt, 
1985), the specific productivities were calculated 
for the system and for its sections (bioreactor 
vessel, perfusion loop, bleed tank). 
Results 
The growth curve is shown in Fig. 11. Using an 
inoculum from another bioreactor, cell prolifera- 
tion and product formation started at relatively 
high concentrations and without a lag period. 
During batch phase growth was unlimited (Figs. 
period 1 
(batch phase) 
period 2 
(lst perfusion phase) 
period 3 
(lst perfusion phase) 
period 4 
(lst perfusion phase) 
period 5 
(lst recycling phase, 
2nd perfusion phase) 
period 6 
(1st recycling phase, 
2nd perfusion'phase) 
period 7 
(2nd recycling phase, 
3rd perfusion phase) 
batch 
t = 0 h to 25.75 h 
perfusion with Dp = 0.62/d 
t = 25.75 h to 49 h 
perfusion with Dp = 0.95/d 
t = 49 h to 74.5 h 
perfusion with Dp = 0.95/d 
bleed with Db = 0.23/d 
t = 74.5 h to 90 h 
perfusion with Dp = 0.95/d 
bleed with Db = 0.23/d 
t = 90 h to 123.25 h
perfusion with Dp = 0.95/d 
bleed with Db = 0.52/d 
t = 123.25 h to 137 h 
perfusion with Dp = 0.95/d 
bleed with Db = 0.52/d 
t = 137 h to 175 h 
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11 and 13). A growth rate of 1.05 per day was 
stable up to the start of period 3. Then growth 
was limited by numerous components (Fig. 13), 
changed into a steady state at 7 million viable 
cells per ml and remained constant during the 
recycling (period 5). At period 6 the bleed rate 
was raised distinctly in respect to the accumula- 
tion of dead cells. Subsequently a decrease of 
viable cells was observed in the bioreactor. 
Glucose, lactate and ammonium concentra- 
tions are plotted in Fig. 13. The glucose uptake 
rate in batch phase was 1.20 g per day per 109 
cells. The production rates for lactate, ammonium 
and alanine in batch phase were 0.93 g, 17.2 mg 
and 35.0 gM per day per 109 cells. During the 
first perfusion period glucose was totally con- 
sumed. Subsequently the glucose concentration 
was raised to nearly double that in the intake by 
increased supplementation via feed. The course 
of amino acid metabolism looked similar, uptake 
rates are listed in Table 4, and concentrations at 
turning-points of the periods in the presented 
culture are shown in Figs. 4, 5, 6, 9 and 10. The 
concentrations of the potential inhibitors lactate, 
ammonium and alanine kept constant during the 
continuous cultivation. Neither lactate (_<2.0 g/l) 
nor ammonium (_<82 mg[l) reached a level that is 
Table 4. Cell specific uptake rates during the batch period of the 
MCB fermentation. 
Amino acid Uptake rate 
(l.tmol/d- 109 ceils) 
Asp 42.2 
Glu 21.6 
Asn 29.8 
Ser 70.7 
His 91.0 
Gln 3650 
Gly 18.3 
Thr 183.6 
Arg 184.0 
Tyr 135.8 
Trp 25.8 
Met 72.8 
Val 183.5 
Phe 78.8 
Ile 180.0 
Leu 291.0 
Lys 259.0 
Ala was produced 
Cys was not analyzed 
Pro was not analyzed 
Glucose 1.20 g/d. 109 cells 
toxic in our experience, and probably the same is 
valid for alanine (<2 mM). 
Figure 12 illustrates the product concentration 
in the bioreactor vessel and in the perfusion tanks 
p l and p2. The product titer in the bioreactor 
increased to 850 mg/1 during the perfusion mode 
(period 2 to 4). At the same time about 260 mg/1 
were collected in the perfusion outlet tank (see 
data 'antibody concentration i tank p2' of Fig. 
12). At period 4 the dilution rate was increased by 
activating the bleed. In the sequel the product 
concentration i the bioreactor was between 600 
to 700 mg/1. At the same time the perfused 
medium with 260 mg/1 product was re-used. In 
the course of the first recycling period (period 5 
and 6) the product concentration rose to 450 mg/l 
(see data 'antibody concentration i tank pl '). In 
period 6 the bleed rate was distinctly increased. 
During the second recycling period (period 7) the 
product concentrations remained constant in the 
bioreactor and in the perfusion tanks (Fig. 12). 
Further product was only gained in the bleed. 
Calculation of the cell specific parameters 
show a constant cell specific productivity during 
the fermentation (Table 5). Therefore, the me- 
dium recycling had no detrimental effect on prod- 
uct formation. The volumetric productivity de- 
creased uring the second recycling period. This 
is certainly not due to the recycling operation but 
due to the decrease in viable cell number at this 
period (see Table 5 and Fig. 11). The latter 
obviously dropped because of the increased bleed 
rate (0.52/d). Apparently a growth inhibition oc- 
curred, because gmax was 1.05/d in batch phase 
and the analyzed substrates (glucose, amino acids 
besides cysteine and proline) were no longer 
minimal at that time. 
The overall product concentration i the entire 
system (bioreactor vessel, bleed tank, perfusion 
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tanks) is shown in Fig. 14. At period 1 to 4 (Batch 
and perfusion with fresh medium) 2997 mg anti- 
body were produced in 90 h. At period 5 to 6 
(first recycling) 1349 mg were formed in 47 h 
and at period 7 (second recycling) 681 mg were 
formed in 38 h (Fig. 14). The production efficien- 
cy in advance of the recycling (33 mg/h) did not 
change substantially during the first recycling (29 
mg/l) and decreased uring the second recycling 
(18 mg/l). 
The medium costs are also mentioned in Fig. 
14. For a medium investment of one German 
Mark, 43.6 mg antibody was produced in advance 
of the recycling, 67.7 mg were produced uring 
the first recycling and 40.1 mg during the second 
recycling. Referred to the expended medium 
costs the 1.5 fold product quantity was obtained 
in the first and the same quantity was obtained in 
the second recycling period as in the perfusion 
period with fresh medium. 
Using the recirculated medium instead of fresh 
medium, the medium costs were reduced from 
56.10 DM to 12.93 DM in respect of the first 
recycling (saving of 77%), and from 56.10 DM to 
16.81 DM in respect to the second recycling 
(saving of 70%). Applied to the overall culture 
Table 5. Specific (q) and volumetric (Q) productivities during the seven periods of the MCB fermentation. 
Period 1 2 3 4 5 6 7 
q (mg/d.109 cells) 121 127 113 147 144 not calculated 144 
Q (mg/d.l) 103 375 690 1024 1040 not calculated 630 
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43% of the costs for the serum-free medium were 
saved (Fig. 15). 
The reduction of waste water quantity, which 
has to be inactivated before disposal, was 80%, 
74% and 45% regarding the first, second recy- 
cling step and the overall culture respectively 
(Fig. 15). 
A one-fold recirculation of the spent medium 
is recommended for this culture. For the inspected 
cell line the specific and volumetric productivity, 
in addition to the cell growth during the first 
recycling period, were comparable to those at the 
preceding perfusion period with fresh medium. 
During the second recycling period the volume- 
tric productivity decreased. This can be explained 
by the decreasing number of viable cells in the 
bioreactor or to a degradation of the product. 
Product degeneration should be avoided by coo- 
ling the peripheral medium tanks. The cell de- 
crease was caused by too great an increase in 
bleed rate at that time, or by growth inhibition as 
a result of insufficient detoxification of detrimen- 
tal substances in the medium. If medium recy- 
cling and medium exchange are done alternately, 
the inspected culture should be able to be per- 
formed also in long-term operation. 
Consequently, the medium cycle bioreactor 
concept was tested in long-term operation in the 
same bioreactor unit in 2 liter scale. In this 
subsequent study the spent perfusion medium 
was re-used once (as recommended above) and 
then discarded and replaced by fresh medium that 
was also re-used once and then discarded, etc. 
B ol  ~1 ~2 ~2 ~3 n) P4 ~4 
j Y- \ . /  
07 
/ )  f i 
-/ _ f  
~s R~ P6 ~s p~ R~ p8 ~B ~ 
\ / \ / \ / \ z< 
0 200 400 600 800 
perfusion (1.00/d} and bleed (g.225/d) since 45 h 
B = batch phase, P3 = 3rd perfusion phase, R7 
n~ M~ nl0 
7:2 ~ 
1,5 ~ 
o 
0,5 
0 
I 000  1200 lgO0 
fermentation time t ime (h )  
= 7th  recycling phase, etc. 
Fig. 16. Growth and product concentration curves of a long- 
term MCB fermentation. 
Figure 16 shows the result of a 1500 h fermenta- 
tion (62.5 days). As in the previous fermentation 
(Figs. 11-13) the vertical bars in Fig. 16 indicate 
the start of respective new perfusion and recy- 
cling periods. Beyond the 45 h batch period 
constant rates for perfusion (1.00/d) and cell 
bleed (0.225/d) were run. P1 is the first perfusion 
period with the fresh medium, followed by me- 
dium re-use, supplementation and by the first 
recycling period (R1), then followed by use of 
new medium and by the second perfusion period 
(P2), then followed by medium re-use, supple- 
mentation and by the second recycling period 
(R2), then followed by P3, R3, P4, R4, P5, etc. 
The cells grew to nearly 7 million viable cells 
per ml at the end of P1. Interruption of nutrient 
feed or gas supply caused a decline in cell num- 
ber during R1, R2 and R3, but the cells recovered 
well each time. Since P4 no further complications 
arose and a steady state at constant cell number 
was maintained. Thus, the cell growth was not 
affected perceptibly by the numerous one-fold 
recycling procedures. 
Below the uppermost three curves (total, viable 
and dead cells) of Fig. 16 the antibody concentra- 
tions in the bioreactor vessel (upper twisted curve), 
in the perfusion outlet tank (lower twisted curve) 
and in the perfusion inlet tank during the R 
periods (intense beam curve) are plotted. Obvi- 
ously, the antibody concentrations during the P 
periods (fresh medium) were zero in the perfu- 
sion inlet tank. Antibody production was about 
the same both during perfusion periods with fresh 
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Fig. 17. SDS-PAGE of bioreactor samples from different P or R periods. Indicated atthe left: samples (lane 2-9 and 11-17): 
non-reduced, appl.: sample application area, MoAb: monoclonal antibody (121 kD), BSA: bovine serum albumin (54 kD), light chain: 
additional light chain of monoclonal antibody (23 kD). Indicated atthe right: standard (lane 1, 10, 18): reduced, phosphorylase b (94 
kD), albumin (67 kD), ovalbumin (43 kD), carbonic anhydrase (30 kD), trypsin inhibitor (20.1 kD), lactalbumin (14.4 kD). 
and re-used medium respectively and during the 
different culture periods. Thus, medium recycling 
is suitable for long-term application. To indicate 
the stability of the product, a gel electrophoresis 
was made of bioreactor samples in the middle of 
different P or R periods (Fig. 17). The antibody 
zones were consistent during the culture. With 
reference to the overall culture with one-fold 
medium re-use, the medium costs were reduced 
from 1835 DM to 1150 DM (saving of 37%) and 
the medium volume was reduced from 161 liter 
to 100.5 liter (saving of 38%). 
Discussion 
Medium recycling is feasible in a very simple 
way, as shown in the presented culture. Setting 
suitable flow rates for perfusion and bleed leads 
to a renunciation of technical systems for protein 
retention and inhibitor removal. The recycling 
procedure achieves considerable r duction of me- 
dium costs and a substantial drop of waste water 
quantity. The medium cycle bioreactor uses the 
classic perfusion mode and needs about he same 
expense for construction and operation as classic 
perfusion systems. The MCB permits a homo- 
geneous cultivation in steady state with extremely 
economic exploitation of the cell culture me- 
dium. 
How many times may the spent medium be 
recirculated? In general the r cycling procedure 
can be repeated until harmful effects occur for 
cell growth or productivity. If those effects ap- 
pear, the recycled medium should be taken out of 
the system and be replaced by fresh medium. 
After that the recycling procedure starts anew. 
Subsequent studies will investigate long-term 
operation with this system. Besides, possible in-
hibitors ought to be detected quickly with a 
variant of the MCB. With this, the cell-free 
perfusion outlet fluid is collected irectly in the 
perfusion inlet tank again. Simultaneous to the 
cell bleed the same quantity of medium concen- 
trate is pumped constantly into the perfusion inlet 
tank. In this especially dynamic recirculation sys- 
tem, detrimental events would take effect at once 
to the cell culture. 
Such effects relative to the specific productiv- 
ity were not obtained uring the second recycling 
phase of the presented 175 h culture. Maintaining 
the primary bleed rate probably did not diminish 
the viable cell number and hence the volumetric 
productivity during the second recycling period. 
Finally, the 1500 h culture with one-fold medium 
recycling and constant bleed rate (20% of the 
total dilution rate) gave no indication that cell 
growth or specific and volumetric productivity 
deteriorated when the spent and supplemented 
medium was fed into the bioreactor. Similar to 
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our results,  Mizrah i  and Av ihoo  (1977) found 
that the spent med ium could be re-used once and 
that loss in cel l  growth appeared ur ing a two-  
fo ld re-use. 
Apparent ly  this MCB process with one- fo ld  
med ium re-use can be used long- term and is as 
e legant  and as ef fect ive as a normal  perfus ion 
system. A l though the med ium recyc l ing and with 
this the economic  per iod  only occurred for every 
other phase (R1, R2, R3, etc.), more  than a third 
of  cel l  culture water  (38%) and med ium costs 
(37%) were saved. Hence,  with a one- fo ld  recy-  
c l ing we a l ready get a substant ia l  reduct ion of  
process costs. 
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